0001214659-18-002132.txt : 20180313 0001214659-18-002132.hdr.sgml : 20180313 20180313215332 ACCESSION NUMBER: 0001214659-18-002132 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180309 FILED AS OF DATE: 20180313 DATE AS OF CHANGE: 20180313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARLIANT RONALD CENTRAL INDEX KEY: 0001288093 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 18688239 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 MARINA BOULEVARD STREET 2: SUITE 250 CITY: BRISBANE STATE: CA ZIP: 94005-1878 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 1000 MARINA BOULEVARD STREET 2: SUITE 250 CITY: BRISBANE STATE: CA ZIP: 94005-1878 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-41404.xml PRIMARY DOCUMENT X0306 4 2018-03-09 0001293310 HUMANIGEN, INC HGEN 0001288093 BARLIANT RONALD C/O HUMANIGEN, INC. 1000 MARINA BOULEVARD, SUITE 250 BRISBANE CA 94005-1878 true false false false Stock Option (Right to Buy) 0.665 2018-03-09 4 A false 715877 0 A 2018-06-30 2028-03-08 Common Stock 715877 715877 D Stock Option (Right to Buy) 0.665 2018-03-09 4 A false 156863 0 A 2018-03-09 2028-03-08 Common Stock 156863 156863 D The option vests in 12 ratable quarterly installments commencing June 30, 2018. These stock options were granted in lieu of the cash compensation payable to Mr. Barliant in respect of his services as a director during 2017. /s/ Deborah Brown, Attorney-In-Fact 2018-03-13